Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics

Rheumatoid arthritis (RA) is a chronic inflammatory disease that is very complex and heterogeneous. If not adequately treated, RA patients are likely to manifest excess of morbidity and disability with an important impact on the quality of life. Pharmacological treatment is based on the administrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Conti, Valeria, Corbi, Graziamaria, Costantino, Maria, De Bellis, Emanuela, Manzo, Valentina, Sellitto, Carmine, Stefanelli, Berenice, Colucci, Francesca, Filippelli, Amelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765045/
https://www.ncbi.nlm.nih.gov/pubmed/33327600
http://dx.doi.org/10.3390/biom10121672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765045/
https://www.ncbi.nlm.nih.gov/pubmed/33327600
http://dx.doi.org/10.3390/biom10121672

Ejemplares similares